Table 4. rs1047972 and rs8173 variants of the AURKA gene and their association with the breast cancer group.

Variant	Genotype	Variable	OR (95% CI)	p-value
rs1047972	CT	Overweight	2.6 (1.26–5.67)	0.010
	CTTT		2.3 (1.17–4.46)	0.016
	CT	Obesity	3.2 (1.60–6.66)	0.001
	CTTT		2.5 (1.32–4.87)	0.005
	CTTT	Family history of cancer	1.9 (1.03–3.68)	0.038
	CTTT	Estrogen receptor plus obesity	2.5 (1.11–5.79)	0.027
	CTTT	Ki-67 (≥ 20%) plus family history of cancer	2.66 (1.14–6.2)	0.023
rs8173	CG	Chemotherapy gastric toxicity	1.6 (1.05–2.46)	0.029
	CGGG		1.7 (1.11–2.72)	0.015
	CGGG	Estrogen receptor plus chemotherapy gastric toxicity	2.0 (1.15–3.48)	0.013
	CGGG	Progesterone receptor plus chemotherapy gastric toxicity	2.6 (1.42–4.9)	0.002
	CGGG	Menopause plus chemotherapy gastric toxicity	2.0 (1.15–3.7)	0.014

p-value less than 0.05 considered statistically significant.

OR = odds ratio; CI =confidence intervals.